Auris Medical Holding AG (EARS) to Release Earnings on Tuesday

  • Auris Medical Holding AG (EARS) to Release Earnings on Tuesday

Auris Medical Holding AG (EARS) to Release Earnings on Tuesday

$5.83's average target is 525.54% above currents $0.932 stock price. The older the historical return data is, the more likely it is to be less useful when predicting future returns.

More notable recent Auris Medical Holding AG (NASDAQ:EARS) news were published by: which released: "Auris Medical Completes Acquisition of AM-125 Assets" on July 20, 2017, also with their article: "Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden ..." published on November 28, 2017, published: "Auris Medical Holding AG to Host Earnings Call" on November 28, 2017.

Analysts see little impact on the stock market. The company has its outstanding shares of 40.75M. If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it.

Looking into last 5 trades, the stock observed a return of nearly 2.17%.

Last year, Keyzilen failed an earlier Phase III trial, missing its co-primary endpoints in the TACTT2 study-the change in subjective tinnitus loudness (tinnitus loudness question; TLQ) and the change in tinnitus burden measured by the Tinnitus Functional Index (TFI) from baseline to day 84 over placebo. This is a problem for day traders and it could mean the difference between a profitable and non-profitable trade. Often, a boost in the volume of a stock is a harbinger of a price jump, either up or down.

When we see the company's Volatility, it now has a monthly volatility of 7.34% and weekly volatility of 8.50%. More volatility means greater profit or loss.

At the moment 2 analysts are watching Auris Medical Holding AG (NASDAQ:EARS), 0 rate it "Buy", 2 "Outperform", 0 "Underperform", 0 "Sell", while 0 "Hold". The stock exchanged hands 2.75 Million shares versus average trading capacity of 538.93 Million shares, yielding a market cap of $33.62 Million.

A moving average (MA) is a trend-following or lagging indicator because it is based on past prices. The high and low revenue estimates for the current quarter are $0 and $0, respectively. The company has Relative Strength Index (RSI 14) of 26.79 together with Average True Range (ATR 14) of 0.06.

Data from the Assent study was expected in the second half of next year. Its quick ratio for the most recent quarter is N/A. Analysts mean recommendation for the stock is 2.00.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), OCUL is given a 2.10 while 2.00 placed for EARS. Bellevue Asset Management AG is the second biggest holder with 2 million shares now valued at 1.64 million whilst Zuercher Kantonalbank has 2 million shares valued at 2.32 million. Hot Stocks Point (HSP) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own.